Mette J. Nielsen
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767.
Journal: Hepatology communications
Published: March 13, 2024
PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease.
Journal: JHEP reports : innovation in hepatology
Published: November 16, 2022
Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 11, 2022
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV.
Journal: BMC infectious diseases
Published: March 11, 2022
Heat-Inactivated Akkermansia muciniphila Improves Gut Permeability but Does Not Prevent Development of Non-Alcoholic Steatohepatitis in Diet-Induced Obese Ldlr-/-.Leiden Mice.
Journal: International journal of molecular sciences
Published: December 16, 2021
Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells.
Journal: Biomedicines
Published: December 02, 2021
Serologically assessed heat shock protein 47 is related to fibrosis stage in early compensated alcohol-related liver disease.
Journal: Clinical biochemistry
Published: October 19, 2021
An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 18, 2021
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure.
Journal: JHEP reports : innovation in hepatology
Published: June 29, 2021
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma.
Journal: Hepatic oncology
Published: June 04, 2021
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial.
Journal: Hepatology (Baltimore, Md.)
Published: May 27, 2021
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3).
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 19, 2021
Last Updated: 09/26/2026